Global Animal Biotechnology Market Growth (Status and Outlook) 2023-2029

Global Animal Biotechnology Market Growth (Status and Outlook) 2023-2029

Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.

LPI (LP Information)' newest research report, the “Animal Biotechnology Industry Forecast” looks at past sales and reviews total world Animal Biotechnology sales in 2022, providing a comprehensive analysis by region and market sector of projected Animal Biotechnology sales for 2023 through 2029. With Animal Biotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Biotechnology industry.

This Insight Report provides a comprehensive analysis of the global Animal Biotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Biotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Biotechnology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Biotechnology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Biotechnology.

The global Animal Biotechnology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Animal Biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Animal Biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Animal Biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Animal Biotechnology players cover Bayer AG, Merck &, Inc., Pfizer, Inc., Sanofi, Biogenesis Bago, Santa Cruz Biotechnology, Inc., Boehringer Inghlem, Virbac Inc. and Zoetis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Animal Biotechnology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines

Segmentation by application
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis

Please note: The report will take approximately 2 business days to prepare and deliver.